| Nome |
# |
|
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors, file dfa8b999-c359-748b-e053-3a05fe0a3a96
|
2360
|
|
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative, file dfa8b9a7-8e60-748b-e053-3a05fe0a3a96
|
235
|
|
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer, file 226480f2-8d43-46fb-933e-6f6798bdaa81
|
211
|
|
The Stearoyl-CoA desaturase1 (SCD) in Drosophila is necessary for Myc induced autophagy, a potential new link to tumor growth, file dfa8b998-15fd-748b-e053-3a05fe0a3a96
|
134
|
|
Transplantation of autologous extracellular vesicles for cancer-specific targeting, file dfa8b9a5-4ee3-748b-e053-3a05fe0a3a96
|
129
|
|
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma, file dfa8b9a0-a0c2-748b-e053-3a05fe0a3a96
|
99
|
|
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence, file dfa8b9a0-78e9-748b-e053-3a05fe0a3a96
|
95
|
|
A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer, file dfa8b9a3-fd4b-748b-e053-3a05fe0a3a96
|
92
|
|
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research, file dfa8b99e-ddf4-748b-e053-3a05fe0a3a96
|
85
|
|
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation, file dfa8b9a3-def3-748b-e053-3a05fe0a3a96
|
85
|
|
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma, file dfa8b9a1-f92b-748b-e053-3a05fe0a3a96
|
79
|
|
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials, file dfa8b9a2-a6d8-748b-e053-3a05fe0a3a96
|
76
|
|
Retroperitoneal pararenal isolated neuro fibroma: report of a case and review of literature, file dfa8b990-5952-748b-e053-3a05fe0a3a96
|
71
|
|
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00, file dfa8b9a6-d5de-748b-e053-3a05fe0a3a96
|
62
|
|
Pulmonary squamous cell carcinoma with lepidic growth pattern : new insights into lung cancer classification, file dfa8b998-0a6b-748b-e053-3a05fe0a3a96
|
55
|
|
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group, file dfa8b9a9-1115-748b-e053-3a05fe0a3a96
|
40
|
|
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers, file ad5d0e0e-96e9-4c72-adc5-6ee59820e0de
|
37
|
|
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications, file 9925aec8-6b35-42ec-ba83-700fe8d975a5
|
30
|
|
Targeted-gene sequencing to catch triple negative breast cancer heterogeneity before and after neoadjuvant chemotherapy, file dfa8b9a9-861a-748b-e053-3a05fe0a3a96
|
26
|
|
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model, file 02da569b-8eb5-4721-81d1-7ae86783fbbb
|
20
|
|
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer, file dfa8b9aa-64ca-748b-e053-3a05fe0a3a96
|
13
|
|
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy, file e8b87cc3-b61b-4140-b242-02adfddaf066
|
9
|
|
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors : a Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group : Part 1 : Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research, file dfa8b999-480e-748b-e053-3a05fe0a3a96
|
8
|
|
Towards mm-wave spectroscopy for dielectric characterization of breast surgical margins, file dfa8b99e-f4c7-748b-e053-3a05fe0a3a96
|
6
|
|
Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study, file 2b2a1ab6-145c-4991-beb6-ef7b23aecc99
|
5
|
|
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients, file dfa8b9a9-8059-748b-e053-3a05fe0a3a96
|
5
|
|
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world, file 8f935cd4-bd88-4485-a8b1-0280038feb41
|
4
|
|
Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy, file dfa8b992-3cbf-748b-e053-3a05fe0a3a96
|
4
|
|
Oncological Outcomes of Nipple-Sparing Mastectomy : a Single-Center Experience of 1989 Patients, file dfa8b9a0-2c8b-748b-e053-3a05fe0a3a96
|
4
|
|
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer, file 241ecd39-8259-4d69-aa87-7e445f025d47
|
3
|
|
Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study, file d612beaa-0e18-41ec-806e-7f712efcb7e8
|
3
|
|
ROS1 Gene Fusion in Advanced Lung Cancer in Women : A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm, file dfa8b999-d038-748b-e053-3a05fe0a3a96
|
3
|
|
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast, file dfa8b9a2-c5f1-748b-e053-3a05fe0a3a96
|
3
|
|
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer, file dfa8b9a3-0274-748b-e053-3a05fe0a3a96
|
3
|
|
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer, file dfa8b9a9-d4d9-748b-e053-3a05fe0a3a96
|
3
|
|
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis, file dfa8b9a9-fdab-748b-e053-3a05fe0a3a96
|
3
|
|
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00, file dfa8b995-4307-748b-e053-3a05fe0a3a96
|
2
|
|
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast, file dfa8b998-15e7-748b-e053-3a05fe0a3a96
|
2
|
|
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy, file dfa8b99d-3bbd-748b-e053-3a05fe0a3a96
|
2
|
|
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series, file dfa8b99e-f4c8-748b-e053-3a05fe0a3a96
|
2
|
|
Analysis of Efficacy and Accuracy of 2 Vacuum-Assisted Breast Biopsy Devices: Mammotome and Elite, file 0780fee5-7e25-4660-b57c-887704c657b2
|
1
|
|
Mammographic density to predict response to neoadjuvant systemic breast cancer therapy, file 148345d7-8339-4fe1-87a8-172fae129421
|
1
|
|
Innate immunity in colorectal liver metastases: macrophage morphology and distribution are strong predictors of prognosis: An external validation, file 1804374f-6c68-498d-9c0c-dd0eb8b86493
|
1
|
|
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors, file 1a546335-d67d-46c8-8910-27494840e7a8
|
1
|
|
Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC), file 2dcbfeb8-66d8-4d95-bf94-e969c3e3787a
|
1
|
|
Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma, file 7006c99e-2340-4206-9bd7-a72168e602d5
|
1
|
|
The impact of COVID-19 on diagnosis of recurrent breast cancer, file 7de088ff-b9c8-4379-9fd0-5994a710e529
|
1
|
|
Salivary gland choristoma in large bowel, file a469d180-83e1-42d2-b195-2f498b3f07f4
|
1
|
|
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer, file ad980ca1-3618-45de-8ee9-6bde28dabce8
|
1
|
|
Solitary thyroid metastasis from colon cancer: A rare case report, file bf98ee39-d303-4b88-83c6-9fcfadffefdd
|
1
|
|
First report of AURORA, the breast international group (BIG) molecular screening initiative for metastatic breast cancer (MBC) patients (pts), file db3cd6e2-31ed-482c-a3cd-89a1059b69ce
|
1
|
|
Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients, file dfa8b996-8bc8-748b-e053-3a05fe0a3a96
|
1
|
|
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy, file dfa8b99d-d35e-748b-e053-3a05fe0a3a96
|
1
|
|
Malignant salivary gland tumours in families with breast cancer susceptibility, file dfa8b9a7-6885-748b-e053-3a05fe0a3a96
|
1
|
|
Fatty acid uptake as a potentially new resistance mechanism to anti-HER2 treatments in HER2-positive breast cancer, file dfa8b9aa-78f6-748b-e053-3a05fe0a3a96
|
1
|
|
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin, file e44ab2a8-aad2-4311-bde7-0a6ad4f36ffa
|
1
|
|
A single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck, file fb191756-39fe-46b3-baf4-10c66c0f80e1
|
1
|
| Totale |
4125 |